Authors/Disclosures
|
David Schmerler, MD
(Riverhills Neuroscience)
|
No disclosure on file |
|
Sharon S. Simon
(University of Sao Paulo Medical School)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Michael L. Pearlman, MD, PhD
|
No disclosure on file |
|
|
No disclosure on file |
|
Kirk R. Daffner, MD, FAAN
(Brigham & Women's Hospital - Harvard Medical School)
|
The institution of Dr. Daffner has received research support from Azheimer's Association. The institution of Dr. Daffner has received research support from FUJIFILM. |
|
Gloria Von Geldern, MD, FAAN
(University of Washington)
|
The institution of Dr. Von Geldern has received research support from Novartis. The institution of Dr. Von Geldern has received research support from Contineum Therapeutics. Dr. Von Geldern has received personal compensation in the range of $0-$499 for serving as a DSMB member with NIH, NINDS. Dr. Von Geldern has a non-compensated relationship as a editorial board member with MS and Related Disorders Journal that is relevant to AAN interests or activities. |
|
Michael D. Weiss, MD, FAAN
(University of Washington Medical Center, Department of Neurology)
|
Dr. Weiss has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB-RA. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Soleo. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. |
|
|
No disclosure on file |